Various left-wing news organizations completely ignored the bombshell Cass Review, a report commissioned by England’s National Health Services (NHS) which found there was “weak evidence” for the efficacy of puberty blockers in minors, a Daily Caller review found.
CNN, ABC News, Axios and Vox haven’t covered the story on their websites at all. NPR, CBS and NBC have four combined stories on the review, one from NPR, one from CBS and two from NBC.
With a different search term I get one hit on NPR, which redirects to here: https://t.co/CJ6nACPD3g pic.twitter.com/mpcEX47Uqo
— Paul Crowley ⏸️ (@ciphergoth) April 18, 2024
NPR’s one story is a re-direct to their Boston affiliate WPUR and their enterprising weekly show “On Point.”
CBS, to their credit, published one story on the review and its consequences.
NBC, also to their credit, posted two stories on the review, a report which strikes a dagger in the heart of arguments in favor of puberty blockers and youth transitioning.
The review, commissioned by the U.K.’s NHS, was written by Dr. Hilary Cass, a British pediatrician who was awarded an Order of the British Empire in 2015 for her work in pediatrics. (RELATED: WHO Quietly Admits There’s No Solid Scientific Backing For Giving Children ‘Gender Affirming Care’)
The peer-reviewed report found that there is “weak evidence” for the use of puberty blockers “regarding the impact on gender dysphoria, mental or psychosocial health,” according to an overview of the findings.
“For most young people, a medical pathway will not be the best way to manage their gender-related distress. For those young people for whom a medical pathway is clinically indicated, it is not enough to provide this without also addressing wider mental health and/or psychosocially challenging problems,” the overview continued.
Following the report, England’s NHS banned the use of puberty blockers in children in March, except in clinical studies. Scotland’s only clinic that prescribed puberty blockers for children will also stop prescribing them to children under the age of 18, the clinic announced Thursday.